Focused protein degradation is currently being explored instead technique in cancer, whereby the all-natural protein degradation program is co-opted for therapeutic reasons. A short while ago designed novel molecules known as proteolysis-focusing on chimeras (PROTACs) are heterobifunctional molecules with two ligands joined by a linker. One ligand binds into the https://www.directivepublications.org/journal-of-clinical-breast-cancer/